Earnings History Data for Trevi Therapeutics, Inc. (TRVI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Trevi Therapeutics, Inc.
Trevi Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. The company is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis and levodopa-induced dyskinesia in patients with Parkinson's disease. Trevi Therapeutics Inc. is based in New Haven, Connecticut.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06-11-2024 | AH | TRVI | Trevi Therapeutics, Inc. | 220.68 | -0.13 | -0.12 | -0.08 | Trevi Therapeutics EPS of -$0.13 misses by $0.02 [11/6/2024 4:58 PM] |
2.90 | -0.20 (-6.49%) |
3.10 | 0.0 (0.00%) |
0.97 - 4.00 | 703,766 | 350,000 | 411 | ||
| 08-08-2024 | PM | TRVI | Trevi Therapeutics, Inc. | 183.84 | -0.12 | -0.11 | -0.07 | Trevi Therapeutics GAAP EPS of -$0.12 [8/9/2024 8:16 AM] |
2.87 | 0.07 (2.32%) |
2.80 | 0.0 (0.00%) |
0.97 - 4.00 | 42,560 | 160,000 | 6,144 | ||
| 07-05-2024 | AH | TRVI | Trevi Therapeutics | 212.00 | -0.11 | -0.09 | 0.00 | Trevi Therapeutics reports Q1 results [5/7/2024 5:45 PM] |
2.64 | -0.26 (-8.97%) |
2.80 | -0.10 (-3.45%) |
0.97 - 4.00 | 108,010 | 110,000 | 1,946 | ||
| 20-03-2024 | AH | TRVI | Trevi Therapeutics, Inc. | 207.54 | -0.08 | -0.10 | -0.06 | Trevi Therapeutics GAAP EPS of -$0.08 beats by $0.01 [3/20/2024 4:22 PM] |
3.67 | 0.13 (3.81%) |
3.49 | -0.05 (-1.41%) |
0.97 - 4.00 | 563,156 | 310,000 | 7,107 | ||
| 09-11-2023 | AH | TRVI | Trevi Therapeutics, Inc. | 97.37 | -0.08 | -0.09 | -0.12 | Trevi Therapeutics GAAP EPS of -$0.08 beats by $0.01 [11/9/2023 4:28 PM] |
1.30 | -0.05 (-3.69%) |
0.0 | 0.0 (0.00%) |
1.18 - 3.50 | 105,799 | 170,000 | 0 | ||
| 10-08-2023 | AH | TRVI | Trevi Therapeutics, Inc. | 138.16 | -0.07 | -0.09 | -0.14 | Trevi Therapeutics GAAP EPS of -$0.07 beats by $0.02 [8/10/2023 5:48 PM] |
2.38 | -0.01 (-0.42%) |
2.39 | 0.0 (0.00%) |
1.43 - 4.60 | 19,642 | 60,000 | 6,162 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
TRVI | Trevi Therapeutics, Inc. | 181.34 | -0.06 | -0.08 | -0.24 | Trevi Therapeutics GAAP EPS of -$0.06 beats by $0.01 [5/11/2023 4:26 PM] |
2.84 | -0.16 (-5.33%) |
3.00 | 0.0 (0.00%) |
1.43 - 4.68 | 116,338 | 160,000 | 15,032 | |
| 16-03-2023 | AH | 4:05 PM ET (Mar 16) |
TRVI | Trevi Therapeutics, Inc. | 137.82 | -0.06 | -0.10 | -0.28 | Trevi Therapeutics GAAP EPS of -$0.06 beats by $0.03 [3/16/2023 4:16 PM] |
1.80 | -0.01 (-0.55%) |
0.0 | 0.0 (0.00%) |
1.39 - 4.68 | 31,599 | 80,000 | 0 | |
| 10-11-2022 | AH | 4:05 PM ET (Nov 10) |
TRVI | Trevi Therapeutics, Inc. | 112.56 | -0.12 | -0.15 | -0.34 | Trevi Therapeutics GAAP EPS of -$0.12 misses by $0.01 [11/10/2022 4:18 PM] |
1.97 | 0.04 (2.07%) |
0.0 | 0.0 (0.00%) |
0.46 - 4.68 | 39,587 | 60,000 | 0 | |
| 11-08-2022 | AH | 4:05 PM ET (Aug 11) |
TRVI | Trevi Therapeutics, Inc. | 140.43 | -0.14 | -0.21 | -0.49 | Trevi Therapeutics GAAP EPS of -$0.14 beats by $0.04 [8/11/2022 4:30 PM] |
4.13 | -0.14 (-3.28%) |
4.50 | 0.23 (5.39%) |
0.46 - 4.68 | 179,033 | 380,000 | 506 | |
| 12-05-2022 | AH | 4:05 PM ET (May 12) |
TRVI | Trevi Therapeutics, Inc. | 86.66 | -0.24 | -0.31 | -0.43 | Trevi Therapeutics GAAP EPS of -$0.24 beats by $0.04 [5/12/2022 4:30 PM] |
2.20 | 0.15 (7.32%) |
2.03 | -0.02 (-0.98%) |
0.46 - 3.73 | 128,211 | 210,000 | 520 | |
| 17-03-2022 | AH | 4:05 PM ET (Mar 17) |
TRVI | Trevi Therapeutics, Inc. | 37.74 | -0.28 | -0.34 | -0.52 | Trevi Therapeutics GAAP EPS of -$0.28 misses by $0.03 [3/17/2022 4:26 PM] |
1.65 | 0.12 (7.84%) |
1.61 | 0.08 (5.23%) |
0.46 - 2.96 | 279,265 | 642,059 | 2,204 | |
| 10-11-2021 | AH | 4:05 PM ET (Nov 10) |
TRVI | Trevi Therapeutics, Inc. | 30.24 | -0.34 | -0.33 | -0.41 | Trevi Therapeutics EPS beats by $0.12 [11/10/2021 4:49 PM] |
1.16 | -0.01 (-0.80%) |
1.15 | -0.02 (-1.71%) |
1.10 - 3.98 | 2,135,360 | 230,000 | 1,034 | |
| 12-08-2021 | AH | 4:05 PM ET (Aug 12) |
TRVI | Trevi Therapeutics, Inc. | 44.00 | -0.49 | -0.46 | -0.41 | Trevi Therapeutics reports Q2 results [8/12/2021 4:17 PM] |
2.02 | -0.08 (-4.05%) |
2.11 | 0.01 (0.67%) |
1.78 - 6.73 | 35,004 | 20,000 | 110 | |
| 13-05-2021 | AH | 4:05 PM ET (May 13) |
TRVI | Trevi Therapeutics, Inc. | 41.85 | -0.43 | -0.49 | -0.48 | Trevi Therapeutics reports Q1 results [5/13/2021 4:33 PM] |
2.03 | 0.02 (1.00%) |
0.0 | 0.0 (0.00%) |
1.94 - 8.50 | 66,717 | 30,000 | 0 | |
| 25-03-2021 | AH | 4:05 PM ET (Mar 25) |
TRVI | Trevi Therapeutics, Inc. | 51.83 | -0.52 | -0.45 | -0.19 | Trevi Therapeutics reports Q4 results [3/25/2021 4:18 PM] |
2.68 | 0.16 (6.35%) |
2.70 | 0.09 (3.45%) |
1.33 - 8.50 | 21,853 | 60,000 | 530 | |
| 12-11-2020 | AH | 4:05 PM ET (Nov 11) |
TRVI | Trevi Therapeutics, Inc. | 61.29 | -0.41 | -0.59 | -0.41 | Trevi Therapeutics reports Q3 results [11/11/2020 4:20 PM] |
3.48 | -0.34 (-8.80%) |
3.65 | -0.17 (-4.35%) |
1.33 - 8.50 | 26,569 | 13,646 | 330 | |
|
|
||||||||||||||||||
| 13-08-2020 | AH | 4:05 PM ET (Aug 13) |
TRVI | Trevi Therapeutics, Inc. | 103.85 | -0.41 | -0.51 | -0.63 | 5.68 | 0.02 (0.44%) |
5.66 | 0.0 (0.00%) |
1.33 - 8.50 | 83,680 | 319,349 | 1,262 | ||
|
|
||||||||||||||||||